On use of animal models

Area of Science:

• Reproductive immunology
• Maternal-fetal immune tolerance
• Pregnancy complications

Background:

• Human pregnancy is susceptible to immunological complications like recurrent miscarriages (RM) and preeclampsia (PE).
• The semi-allogeneic nature of the fetus necessitates immune tolerance mechanisms.
• Mouse models, particularly CBA/J x DBA/2, are vital for studying RM and PE.

Purpose of the Study:

• To investigate the immunological mechanisms underlying pregnancy success and failure.
• To identify key immune cells and molecules involved in preventing fetal rejection.
• To explore therapeutic strategies for improving pregnancy outcomes.

Main Methods:

• Utilized the CBA/J x DBA/2 mouse model for recurrent miscarriage studies.
• Investigated the role of T cell receptor (TcR) bearing cells, including αβ TcR and γδ TcR T cells.
• Examined the function of regulatory T cells (Tregs) and innate immune cells like NK cells and macrophages.
• Assessed the impact of immune checkpoint inhibitors (CD200) and Intralipid on pregnancy outcomes.

Main Results:

• Antigen-specific Tregs activated by semen antigens are protective against fetal loss.
• Inadequate Treg responses and pro-inflammatory cytokines from innate immune cells contribute to RM.
• γδ TcR cells protect via TGF-β release, while CD200 enhances decidual suppressor cell activity.
• Intralipid improves LPS clearance, prevents abortions in mice, and increases live birth rates in human IVF.

Conclusions:

• Immune regulation, particularly by Tregs and specific innate immune cells, is critical for successful pregnancy.
• Targeting immune pathways, such as with CD200 or Intralipid, offers potential therapeutic benefits for pregnancy complications.
• Understanding immune interactions is key to addressing infertility, miscarriage, and preeclampsia.